Neuraminidase
Neuraminidase structure
|
Common Name | Neuraminidase | ||
|---|---|---|---|---|
| CAS Number | 9001-67-6 | Molecular Weight | 226.232 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 656.2±55.0 °C at 760 mmHg | |
| Molecular Formula | C9H14N4O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 350.7±31.5 °C | |
Use of NeuraminidaseNeuraminidase (Exo-α-sialidase) is an exosialidase, is often used in biochemical studies. Neuraminidase cleaves α-ketosidic linkage between the sialic (N-acetylneuraminic) acid and an adjacent sugar residue. Neuraminidase, derived from mucosal pathogens, is a virulence factor that modifies the host's response to infection[1]. |
| Name | carnosine |
|---|---|
| Synonym | More Synonyms |
| Description | Neuraminidase (Exo-α-sialidase) is an exosialidase, is often used in biochemical studies. Neuraminidase cleaves α-ketosidic linkage between the sialic (N-acetylneuraminic) acid and an adjacent sugar residue. Neuraminidase, derived from mucosal pathogens, is a virulence factor that modifies the host's response to infection[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 656.2±55.0 °C at 760 mmHg |
| Molecular Formula | C9H14N4O3 |
| Molecular Weight | 226.232 |
| Flash Point | 350.7±31.5 °C |
| Exact Mass | 226.106583 |
| LogP | -2.17 |
| Appearance of Characters | lyophilized powder | white |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.591 |
| Storage condition | 2-8°C |
| Water Solubility | Soluble in water or 10mM phosphate buffer, pH 6.0 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | QQ3450000 |
|
Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.
Influenza Other Respi. Viruses 7 Suppl 1 , 14-24, (2013) The objectives of this study were to: (1) reflect on key stages in the discovery, development and pre-pandemic use of neuraminidase inhibitors (NAIs), (2) summarise the evidence of NAI effectiveness f... |
|
|
Genetic ancestor of external antigens of pandemic influenza A/H1N1 virus.
Interdiscip. Sci. 4(4) , 282-90, (2012) The aim of the present investigation was to discover the genetic relationships of 2009 pandemic novel influenza A/H1N1 virus (NIV) external antigens Hemagglutinin (HA) and Neuraminidase (NA) with othe... |
|
|
Nucleic acid-based detection of influenza A virus subtypes H7 and N9 with a special emphasis on the avian H7N9 virus.
Euro Surveill. 19(10) , (2014) In 2013, a novel influenza A virus of subtype H7N9 was transmitted from avian sources to humans in China, causing severe illness and substantial mortality. Rapid and sensitive diagnostic approaches ar... |
| 2-[(3-Aminopropanoyl)amino]-3-(1H-imidazol-4-yl)propanoic acid |
| Histidine, β-alanyl- |
| b-Alanylhistidine |
| β-Alanylhistidine |
| carnosine |
| EINECS 232-624-6 |
| MFCD00131711 |
| N-(3-Aminopropanoyl)histidine |